EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Caregiver Mental Health and Its Relation to Child and Adolescent Mental and Behavioral Health in the Era of Highly Effective Modulator Therapy for Cystic Fibrosis

Christina L Duncan iD, Megan von Isenburg iD, Angela Green iD, Christine Ford iD, Austin Pucci iD, Emily F Muther iD, Kristin A Riekert iD, Evelyn Bord, Jordana E Hoppe iD, Callie Bacon, Andrea Goodman, Emma Lyons iD und 3 weitere

Pediatric Pulmonology · 2026-08 · 61 (8)

DOI: 10.1002/ppul.71794 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Pulmonology, online erschienen am 20.08.2026. Verfasst von Christina L Duncan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Oklahoma State University, Stillwater, Oklahoma, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Caregivers, Depression, Mental Health. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cystic Fibrosis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Elexacaftor/tezacaftor/ivacaftor (ETI) has led to marked improvements in physical health outcomes but inconsistent findings regarding changes in mental and behavioral health outcomes for youth with cystic fibrosis (YWCF) and their caregivers.

Objectives

To describe the prevalence of mental/behavioral health symptoms in YWCF taking ETI and their caregivers, and to examine the association between caregiver and youth mental/behavioral health symptoms.

Method

In this cross‐sectional study, 118 YWCF (ages 7–17) and their caregivers from 11 U.S. CF centers participated. Standardized self‐report and parent‐proxy screening measures assessed symptoms of depression, anxiety, attention deficit hyperactivity disorder (ADHD), externalizing behaviors, and sleep disturbance. Descriptive statistics summarized prevalence and Spearman Rho correlations were used to analyze associations.

Results

The point prevalence of mild or moderate/severe depressive symptoms was 23.3% (95% CI: 16, 31) for caregivers, 27.1% (95% CI: 15, 40) for children (ages 7–12), and 28.6% (95% CI: 18, 39) for adolescents (ages 13–17). The point prevalence for mild or moderate/severe anxiety symptoms was 23.1% (95% CI: 15, 31) for caregivers, 31.3% (95% CI: 18, 44) for children, and 18.8% (95% CI: 10, 28) for adolescents. Some YWCF exceeded clinical cutoffs for sleep disturbance (29.8–35.0%), attention (11.4–14.9%), and externalizing behavior (5.7–8.5%). Caregiver mental health scores and child mental/behavioral health scores were positively correlated (ρ = 0.20 − 0.52, p 's < 0.05).

Conclusions

Though most YWCF and caregivers report few to no mental/behavioral health symptoms, many still report clinically elevated levels, suggesting the continued need to screen for mental health concerns in the evolving context of highly effective CF treatment. Our results also indicate that screening should expand to areas beyond anxiety and depression, such as sleep, as well as the possible need for developing family‐based mental health care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCaregiversDepressionMental HealthHumansChildAdolescentFemaleCross-Sectional StudiesMaleAnxietyQuinolonesDrug CombinationsPrevalenceBenzodioxolesSleep Wake DisordersUnited StatesIndolesAttention Deficit Disorder with HyperactivityPyrrolidinesPyridines

Substanzen

QuinolonesDrug CombinationsBenzodioxolestezacaftorIndolesPyrrolidinesPyridines

Autor:innen und Institutionen

  • Oklahoma State University, Stillwater, Oklahoma, USA.
  • Community Partner, Durham, North Carolina, USA.
  • Johns Hopkins University, Baltimore, Maryland, USA.
  • University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Boston Children's Hospital, Boston, Massachusetts, USA.
  • Northwestern University School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Christina L Duncan, Megan von Isenburg, Angela Green, Christine Ford, Austin Pucci, Emily F Muther, Kristin A Riekert, Jordana E Hoppe, Emma Lyons, Robin S Everhart

Förderung

  • Cystic Fibrosis Foundation

Zitieren

APA

Duncan, C. L., von Isenburg, M., Green, A., Ford, C., Pucci, A., Muther, E. F., Riekert, K. A., Bord, E., Hoppe, J. E., Bacon, C., Goodman, A., Lyons, E., Prickett, M., Gibson, S. L., & Everhart, R. S. (2026). Caregiver Mental Health and Its Relation to Child and Adolescent Mental and Behavioral Health in the Era of Highly Effective Modulator Therapy for Cystic Fibrosis. Pediatric Pulmonology, 61(8). https://doi.org/10.1002/ppul.71794

Vancouver

Duncan CL, von Isenburg M, Green A, Ford C, Pucci A, Muther EF, et al. Caregiver Mental Health and Its Relation to Child and Adolescent Mental and Behavioral Health in the Era of Highly Effective Modulator Therapy for Cystic Fibrosis. Pediatric Pulmonology. 2026;61(8). doi:10.1002/ppul.71794

BibTeX
@article{Duncan2026,
  author = {Duncan, Christina L and von Isenburg, Megan and Green, Angela and Ford, Christine and Pucci, Austin and Muther, Emily F and Riekert, Kristin A and Bord, Evelyn and Hoppe, Jordana E and Bacon, Callie and Goodman, Andrea and Lyons, Emma and Prickett, Michelle and Gibson, Sidney L and Everhart, Robin S},
  title = {Caregiver Mental Health and Its Relation to Child and Adolescent Mental and Behavioral Health in the Era of Highly Effective Modulator Therapy for Cystic Fibrosis},
  journal = {Pediatric Pulmonology},
  year = {2026},
  volume = {61},
  number = {8},
  doi = {10.1002/ppul.71794}
}
Kostenlos starten →